van de Laar MAFJ - Search Results

1

2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.

Dures E, Farisoğulları B, Santos EJF, Molto A, Feldthusen C, Harris C, Elling-Audersch C, Connolly D, Elefante E, Estévez-López F, Bini I, Primdahl J, Hoeper K, Urban M, van de Laar MAFJ, Redondo M, Böhm P, Amarnani R, Hayward R, Geenen R, Rednic S, Pettersson S, Thomsen T, Uhlig T, Ritschl V, Machado PM. Dures E, et al. Among authors: van de laar mafj. Ann Rheum Dis. 2023 Nov 22:ard-2023-224514. doi: 10.1136/ard-2023-224514. Online ahead of print. Ann Rheum Dis. 2023. PMID: 38050029

2

Predictive value of gastrointestinal symptoms and patient risk factors for NSAID-associated gastrointestinal ulcers defined by endoscopy? Insights from a pooled analysis of two naproxen clinical trials.

van de Laar MAFJ, Schöfl R, Prevoo M, Jastorff J. van de Laar MAFJ, et al. PLoS One. 2023 Apr 13;18(4):e0284358. doi: 10.1371/journal.pone.0284358. eCollection 2023. PLoS One. 2023. PMID: 37053160 Free PMC article.

3

Relative Impact of Pain and Disease Activity on Improvements in Fatigue: Results From 2 Baricitinib Phase 3 Clinical Trials.

Fautrel B, Wu J, Wang D, Haladyj E, van de Laar MAFJ, Takeuchi T. Fautrel B, et al. Among authors: van de laar mafj. J Clin Rheumatol. 2023 Apr 1;29(3):139-144. doi: 10.1097/RHU.0000000000001924. Epub 2022 Dec 7. J Clin Rheumatol. 2023. PMID: 36473106 Free PMC article. Clinical Trial.

4

Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients.

van de Laar CJ, Janssen CA, Janssen M, Oude Voshaar MAH, Al MJ, van de Laar MAFJ. van de Laar CJ, et al. Among authors: van de laar mafj. PLoS One. 2022 Jan 28;17(1):e0261940. doi: 10.1371/journal.pone.0261940. eCollection 2022. PLoS One. 2022. PMID: 35089941 Free PMC article.

5

Healthcare professionals' perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis.

Voshaar MJH, van den Bemt BJF, van de Laar MAFJ, van Dulmen AM, Vriezekolk JE. Voshaar MJH, et al. Among authors: van de laar mafj. BMC Health Serv Res. 2022 Jan 13;22(1):62. doi: 10.1186/s12913-021-07459-0. BMC Health Serv Res. 2022. PMID: 35022034 Free PMC article.

6

Fatigue is associated with disease activity in some, but not all, patients living with rheumatoid arthritis: disentangling "between-person" and "within-person" associations.

Versteeg GA, Ten Klooster PM, van de Laar MAFJ. Versteeg GA, et al. Among authors: van de laar mafj. BMC Rheumatol. 2022 Jan 7;6(1):3. doi: 10.1186/s41927-021-00230-2. BMC Rheumatol. 2022. PMID: 34991729 Free PMC article.

7

Co-Design of a Disease Activity Based Self-Management Approach for Patients with Rheumatoid Arthritis.

Spijk-de Jonge MJ, Manders SHM, Huis AMP, Elwyn G, van de Laar MAFJ, van Riel PLCM, Hulscher MEJL. Spijk-de Jonge MJ, et al. Among authors: van de laar mafj. Mediterr J Rheumatol. 2021 Mar 31;32(1):21-30. doi: 10.31138/mjr.32.1.21. eCollection 2021 Mar. Mediterr J Rheumatol. 2021. PMID: 34386699 Free PMC article.

8

Early radiological progression remains associated with long-term joint damage in real-world rheumatoid arthritis patients treated to the target of remission.

Versteeg GA, Steunebrink L, Vonkeman HE, Ten Klooster PM, Van Der Bijl AE, Van De Laar M. Versteeg GA, et al. Among authors: van de laar m. Scand J Rheumatol. 2022 Mar;51(2):87-96. doi: 10.1080/03009742.2021.1917161. Epub 2021 Jun 21. Scand J Rheumatol. 2022. PMID: 34151716

9

Ranking facilitators and barriers of medication adherence by patients with inflammatory arthritis: a maximum difference scaling exercise.

Voshaar MJH, Vriezekolk JE, van Dulmen AM, van den Bemt BJF, van de Laar MAFJ. Voshaar MJH, et al. Among authors: van de laar mafj. BMC Musculoskelet Disord. 2021 Jan 6;22(1):21. doi: 10.1186/s12891-020-03874-2. BMC Musculoskelet Disord. 2021. PMID: 33407344 Free PMC article.

10

Two parallel short forms to measure disease- and treatment-associated knowledge in rheumatoid arthritis: application of item response theory.

Spijk-de Jonge MJ, Oude Voshaar MAH, Renskers L, Huis AMP, van de Laar MAFJ, Hulscher MEJL, van Riel PLCM. Spijk-de Jonge MJ, et al. Among authors: van de laar mafj. Rheumatol Adv Pract. 2020 Jun 17;4(2):rkaa012. doi: 10.1093/rap/rkaa012. eCollection 2020. Rheumatol Adv Pract. 2020. PMID: 32704614 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page